• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Recalls of Medical Device Regulation Updated

Recalls of Medical Device Regulation Updated

Friday, 16 September 2016 / Published in Medical Device, News

Recalls of Medical Device Regulation Updated

Recalls of Medical Device Regulation Updated .

On September 2nd 2016 a new draft for handling recalls of medical devices has been released. The revision will replace the current regulation 82/2010 from the Chinese Ministry of Health dated 28.06.2010. It describes the key points leading to a recall.

  1. If the medical device poses hazardous risks
  2. If the medical device does not meet the regulation standards
  3. If during manufacturing and/or distribution violations of the current medical device regulations occur
  4. If any further adverse events ask for a recall

The draft also gives some guidelines for the management of recalls.

  1. When the recall occurs outside of China the appropriate departments of the NMPA have to be informed
  2. Within China:
    – Monitoring the safety of medical devices
    – Communication, reporting and close cooperation with the NMPA
    – Organization of the recall – assessment, if applicable relabelling, modification of the quality manual and/or software up-grades. Also of course repairs or replacement of the device and its disposal have to be taken care of.
    – Compensation
    – Penalties

When there is proof of the defectiveness of the device, and the NMPA-Legal-Agent fails to report to the NMPA, the NMPA may initiate the recall.

Violation of the regulations can result in fines for the NMPA Legal Agent or even cost him his license.

Recalls will be published in the NMPA database stating details of the product, its manufacturer and NMPA Legal Agent.

For more information please contact us:

Cisema GmbH
Tel.: +49 89 4161 7389 – 00
Fax: +49 89 7484 9956
info@cisema.de
www.cisema.com

 

What you can read next

China General Cosmetics Urgent Deadline! Annual Reports Due 31 March
NMPA Temporary Rearrangements to Facilitate Registrations Affected by COVID-19
NMPA Technical Review Guidance Draft for Personalized Implants for Additive Manufacturing

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Clinical trials of sodium hyaluronate complex solution

    Clinical trials of sodium hyaluronate complex solution – draft guidelines issued

    Clinical trials of sodium hyaluronate complex s...
  • China registration of ophthalmic optical measurement devices

    China registration of ophthalmic optical measurement devices – Technical review guidelines issued

    China registration of ophthalmic optical measur...
  • Pre-communication for Hainan medical device clinical RWD

    Pre-communication for Hainan medical device clinical RWD application – Trial measures implemented

    Pre-communication for Hainan medical device cli...
  • Registration platform for cosmetic raw materials safety information

    Registration platform for cosmetic raw materials safety information – Draft guidelines issued

    The registration platform for cosmetic raw mate...
  • Technical guidelines for reporting cosmetics formulas

    Technical guidelines for reporting cosmetics formulas – draft issued

    Technical guidelines for reporting cosmetics fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP